Convergence Investment Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,701
| Closed | -$187K | – | 321 |
|
|
2019
Q1 | $187K | Sell |
3,701
-3,807
| -51% | -$192K | 0.04% | 281 |
|
|
2018
Q4 | $445K | Sell |
7,508
-1,185
| -14% | -$70.2K | 0.1% | 198 |
|
|
2018
Q3 | $572K | Sell |
8,693
-10,105
| -54% | -$665K | 0.12% | 202 |
|
|
2018
Q2 | $949K | Sell |
18,798
-62,982
| -77% | -$3.18M | 0.13% | 203 |
|
|
2018
Q1 | $4.31M | Sell |
81,780
-5,533
| -6% | -$291K | 0.56% | 45 |
|
|
2017
Q4 | $4.06M | Buy |
87,313
+36,247
| +71% | +$1.68M | 0.54% | 50 |
|
|
2017
Q3 | $2.07M | Buy |
+51,066
| New | +$2.07M | 0.29% | 134 |
|
|
2017
Q1 | – | Sell |
-37,389
| Closed | -$1.23M | – | 345 |
|
|
2016
Q4 | $1.23M | Sell |
37,389
-11,778
| -24% | -$387K | 0.17% | 239 |
|
|
2016
Q3 | $1.55M | Buy |
+49,167
| New | +$1.55M | 0.23% | 168 |
|
|
2016
Q2 | – | Sell |
-40,818
| Closed | -$1.48M | – | 324 |
|
|
2016
Q1 | $1.48M | Sell |
40,818
-5,320
| -12% | -$193K | 0.18% | 199 |
|
|
2015
Q4 | $1.85M | Sell |
46,138
-4,770
| -9% | -$191K | 0.21% | 175 |
|
|
2015
Q3 | $1.45M | Sell |
50,908
-11,310
| -18% | -$322K | 0.17% | 202 |
|
|
2015
Q2 | $2.05M | Buy |
+62,218
| New | +$2.05M | 0.2% | 168 |
|
|
2014
Q4 | – | Sell |
-58,672
| Closed | -$1.25M | – | 380 |
|
|
2014
Q3 | $1.25M | Buy |
58,672
+17,728
| +43% | +$378K | 0.17% | 190 |
|
|
2014
Q2 | $920K | Sell |
40,944
-9,500
| -19% | -$213K | 0.12% | 253 |
|
|
2014
Q1 | $1.28M | Buy |
50,444
+20,736
| +70% | +$524K | 0.19% | 162 |
|
|
2013
Q4 | $683K | Buy |
+29,708
| New | +$683K | 0.11% | 220 |
|